Most of us microbiologists were rudely awakened to the insufficiency of our susceptibility testing methods last year when the College of American Pathologists (CAP) sent out a carbapenemase-producing Klebsiella pneumoniae as an unknown proficiency testing sample. My laboratory, like most others in the United States, incorrectly reported the isolate as susceptible to imipenem and meropenem.